🇺🇸 FDA
Patent

US 12097223

Mesenchymal stromal cells and uses related thereto

granted A61KA61K35/28A61K35/30

Quick answer

US patent 12097223 (Mesenchymal stromal cells and uses related thereto) held by Astellas Institute for Regenerative Medicine expires Mon Sep 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Astellas Institute for Regenerative Medicine
Grant date
Tue Sep 24 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K35/28, A61K35/30, A61K35/34, A61K35/36